Production (Stage)
Medtronic plc
MDT
$89.92
$0.520.58%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 04/25/2025 | 01/24/2025 | 10/25/2024 | 07/26/2024 | 04/26/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.94% | 2.51% | 5.25% | 2.77% | 0.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.94% | 2.51% | 5.25% | 2.77% | 0.51% |
| Cost of Revenue | 6.18% | 0.18% | 6.88% | 5.36% | 0.44% |
| Gross Profit | 2.75% | 3.72% | 4.39% | 1.43% | 0.55% |
| SG&A Expenses | 6.89% | 2.63% | 3.93% | 2.34% | 5.69% |
| Depreciation & Amortization | 34.61% | -0.72% | -2.82% | -3.50% | -0.95% |
| Other Operating Expenses | 84.43% | -270.59% | -10.64% | 662.50% | -52.29% |
| Total Operating Expenses | 9.66% | -1.33% | 4.25% | 3.92% | -0.06% |
| Operating Income | -17.07% | 18.95% | 9.43% | -2.33% | 2.68% |
| Income Before Tax | 47.20% | 4.62% | 18.81% | 5.93% | -44.77% |
| Income Tax Expenses | 1.02% | 75.56% | -30.10% | -45.00% | -45.58% |
| Earnings from Continuing Operations | 61.00% | -2.54% | 40.40% | 31.49% | -44.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 40.00% | -350.00% | 0.00% | 44.44% |
| Net Income | 61.47% | -2.12% | 39.71% | 31.73% | -44.53% |
| EBIT | -17.07% | 18.95% | 9.43% | -2.33% | 2.68% |
| EBITDA | -11.19% | 14.92% | 6.70% | -2.06% | 0.93% |
| EPS Basic | 66.50% | 1.49% | 44.91% | 35.53% | -44.19% |
| Normalized Basic EPS | 9.18% | 6.42% | 5.27% | -1.45% | -12.47% |
| EPS Diluted | 68.01% | 1.92% | 45.59% | 35.59% | -44.55% |
| Normalized Diluted EPS | 8.98% | 6.28% | 5.03% | -1.43% | -12.51% |
| Average Basic Shares Outstanding | -3.03% | -3.56% | -3.59% | -2.80% | -0.61% |
| Average Diluted Shares Outstanding | -2.84% | -3.42% | -3.38% | -2.80% | -0.56% |
| Dividend Per Share | 1.45% | 1.45% | 1.45% | 1.45% | 1.47% |
| Payout Ratio | -0.39% | 0.00% | -0.30% | -0.26% | 0.82% |